Concepedia

Masaaki Ishibashi

MI

Statistics

Publications

6

Citations

119

H-Index

6

Active since

1992

Affiliations

Mochida Pharmaceutical (Japan)(Current)

Chiba University

SHOWA Medical University

Masaaki Ishibashi is an author at Mochida Pharmaceutical (Japan) specializing in pharmacology, life sciences, and biochemical pharmacology.

Publications per year

1992–2020

6

Publications

6

Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17-icosapentaenoate

Kiyoshi Mizuguchi, Takashi Yano, Yasuo Tanaka et al. · European Journal of Pharmacology · 1993 · 30 citations

, , +10

Possible involvement of TRPM2 activation in 5-fluorouracil-induced myelosuppression in mice

Masaaki Ishibashi, Masakazu Ishii, Shinichiro Yamamoto et al. · European Journal of Pharmacology · 2020 · 21 citations

, , +6

Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein

Kiyoshi Mizuguchi, Takashi Yano, Masaaki Ishibashi et al. · European Journal of Pharmacology · 1993 · 18 citations

, , +12

Hypolipidemic Effect of Ethyl all-cis-5,8,11,14,17-Icosapentaenoate (EPA-E) in Rats.

Kiyoshi Mizuguchi, Takashi Yano, Masahiro Kojima et al. · The Japanese Journal of Pharmacology · 1992 · 18 citations · Full text

, , +15

Protective Action of Ulinastatin against Cisplatin Nephrotoxicity in Mice and Its Effect on the Lysosomal Fragility

Fumiaki Yamasaki, Masaaki Ishibashi, Masanori Nakakuki et al. · ˜The œNephron journals/Nephron journals · 2008 · 17 citations

, , +13

1–5 of 6